California healthcare innovator Amgen, which already has facilities at Cambridge Science Park, has made a new and incisive acquisition in the UK - buying Oxford University spin-out Dark Blue ...
Moment of Clarity has published a new educational resource on insurance coverage considerations for transcranial magnetic ...
Christopher Care Center, a premier provider of detox and residential addiction treatment, is pleased to announce its new range of alcohol and drug specialty programs in Mission Viejo, California. From ...
Amgen’s acquisition of Dark Blue Therapeutics adds a first-in-class leukemia program that aligns with the company’s growing ...
The deal hands Amgen a drug that destroys two proteins known to drive certain types of acute myeloid leukemia, a profile that ...
OXFORD, England, Jan. 6, 2026 /PRNewswire/ -- Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback